Opinion|Videos|February 5, 2024

Approaches to Treating Locally Advanced HER2+ Breast Cancer

Author(s)Rahul Gosain, MD, Rohit Gosain, MD, Harold J. Burstein, MD, PhD

The Oncology Brothers and Harold J. Burstein, MD, PhD, discuss clinical approaches to treating patients with locally advanced HER2+ breast cancer.

Episodes in this series

Rahul Gosain, MD; Rohit Gosain, MD; and Harold J. Burstein, MD, PhD, presenting slides

EP. 1 Treatment Algorithms for Early-Stage HER2+ Breast Cancer

Rahul Gosain, MD; Rohit Gosain, MD; and Harold J. Burstein, MD, PhD, presenting slides

EP. 2 Approaches to Treating Locally Advanced HER2+ Breast Cancer

Rahul Gosain, MD; Rohit Gosain, MD; and Harold J. Burstein, MD, PhD, presenting slides

EP. 3 Treating Patients with Metastatic HER2+ Breast Cancer

Rahul Gosain, MD; Rohit Gosain, MD; and Harold J. Burstein, MD, PhD, presenting slides

EP. 4 Managing Adverse Effects in Patients with HER2+ Breast Cancer

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Related to this article

$Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer$

September 28th, 2026

Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer

10-year CHN HYPOPMRT data show 3-week postmastectomy RT with nodal irradiation maintains locoregional control without added severe late toxicity.

Trending on CancerNetwork

What Does TALAPRO-3 Mean for Frontline Treatment of HRR-Altered mHSPC?

Aglatimagene Combo Shows Sustained Immune Remodeling in Prostate Cancer

CARTITUDE-2 Cohort A Follow-Up Data and Preparing Patients for CAR TCell Therapy

Referral Barriers to Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma

Ciltacabtagene Autoleucel Manufacturing, Debulking, and Bridging in Multiple Myeloma